Oncodesign Announces Unaudited Consolidated Sales Results for the Half Year Ended June 30, 2021
September 16, 2021 at 12:00 pm EDT
Oncodesign announced unaudited consolidated revenue results for the half year ended June 30, 2021. For the half year, the company reported total operating income and revenue of EUR 18.4 million against EUR 18.1 million a year ago. Operating loss was EUR 0.6 million against EUR 0.3 million a year ago. Consolidated net loss was EUR 0.1 million against EUR 0.0 a year ago.